Sino Biopharm - Chia Tai Qingjiang Pharmaceuticals Was Listed as One of the "Top 50 Enterprises" in Huai'an City
Release time：2022-02-14
Recently, Huai'an City held a conference on tackling heavy and mega projects and optimizing business environment, which released the list of "Top 50 enterprises in Huai'an City in 2021", and Chia Tai Qingjiang ranked 16th in the list with excellent results, up 4 places compared with last year.
In 2021, the company achieved sales of RMB891 million and tax revenue of RMB87.99 million, both of which were record highs, and in 2020, the company was ranked among the "Top 100 Industrial Enterprises in China's Chemical Pharmaceutical Industry". In 2021, Chia Tai Qingjiang was again selected as one of the top 50 enterprises in Huai'an City, fully reflecting the company's profound strength, brand influence and the high recognition of the community.
At the same time, being selected again is also a surging impetus for the dream of billion-dollar development in 2022! This year, Chia Tai Qingjiang will move forward with honor, adhering to the corporate mission of "health business, good life", focusing closely on the management policy of "grasping marketing, ensuring medium-speed growth; strong R&D, promoting new drug breakthroughs; emphasizing talent, attracting 100 new students; building new factories, constructing the cornerstone of development". To make greater contribution to the city's economic development of high quality.
